GAMMA Investing’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CIM
EP
FAM
VCM
FFA
IRC
CA
MPWT
DCM
GWM
GAMMA Investing's CNMD Position: Q3 2026 in Review
GAMMA Investing increased its CONMED (CNMD) stake by 0.66% in Q3 2026, buying an estimated $275 and bringing the position to 911 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.
GAMMA Investing first reported a position in CNMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $83.2K in Q3 2025. 11 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- GAMMA Investing held 911 shares of CONMED worth $42.1K as of Q3 2026.
- GAMMA Investing bought 6 CONMED shares in Q3 2026, an estimated $275.
- CONMED made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2480 holding.
- GAMMA Investing first reported a position in CONMED in Q4 2023 and has held it in 12 quarters since.
- GAMMA Investing's CONMED position peaked at $83.2K in Q3 2025.
- 11 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.